# SightLife/CorneaGen – FDA Inspection, Sep 21, 2011

Source: https://www.keypedia.com/records/fda_inspections/sightlifecorneagen/2efc6678-4dd1-45e1-8d10-2c678f14cac8
Source feed: FDA_Inspections

> FDA inspection 745752 of SightLife/CorneaGen, September 21, 2011. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 745752
- Company Name: SightLife/CorneaGen
- Inspection Date: 2011-09-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 981753 - 2016-08-03](https://www.keypedia.com/records/fda_inspections/sightlifecorneagen/02b5d0c7-f842-4416-a9bb-7d064e1fcbb5)
- FDA Inspection 894961 - 2014-09-11
- FDA Inspection 572644 - 2009-03-26

Company: https://www.keypedia.com/companies/sightlifecorneagen/893bd611-bd46-4e4d-bf08-6d9a6272be74

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d